Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.76 |
| ▸ | PPARD | Q03181 | 14/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 5/20 | 0.39 |
| ▸ | SLC8A1 | P32418 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7698317 | 1.00 | SLC6A9 (0.76) | SLC6A9PPARDMTNR1AMTNR1BPPARA | |
| Hydrochloric Acid SCHEMBL7703272 | 0.99 | SLC6A9 (0.75) | SLC6A9PPARDMTNR1AMTNR1BPPARA | |
| Lithium Ion SCHEMBL7711880 | 0.93 | SLC6A9 (0.66) | SLC6A9PPARDMTNR1AMTNR1BPPARA | |
| SCHEMBL1761264 | 0.89 | SLC6A9 (0.81) | SLC6A9PPARDMTNR1AMTNR1BPPARA | |
| Org-25935 SCHEMBL27034881 | 0.87 | SLC6A9 (1.00) | SLC6A9PPARDMTNR1AMTNR1B | |
| Org-25935 SCHEMBL1761267 | 0.87 | SLC6A9 (1.00) | SLC6A9PPARDMTNR1AMTNR1B | |
| Org-25935 SCHEMBL7703430 | 0.87 | SLC6A9 (1.00) | SLC6A9PPARDMTNR1AMTNR1B | |
| Hydrochloric Acid SCHEMBL7711859 | 0.86 | SLC6A9 (0.76) | SLC6A9PPARDMTNR1AMTNR1BPPARA | |
| Hydrochloric Acid SCHEMBL7706014 | 0.86 | SLC6A9 (0.76) | SLC6A9PPARD | |
| SCHEMBL1761249 | 0.86 | SLC6A9 (0.79) | SLC6A9PPARDMTNR1AMTNR1BPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6410592-B1 | THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS | AKZO NOBEL N.V. (NL) | 2002-06-25 | — | — | US | claimed |